Legal costs exceed $15 million in CRISPR patent dispute

Sharon Begley, 12 August 2016, STAT News,

Editas Medicine has spent $15.6 million in legal fees in defense of the CRISPR patents jointly owned by the Broad Institute and Harvard.  Given that a decision is not expected until 2017, the costs will come in well over the $10 million each side was expected to spend.

Author: Advanced Analytical

Advanced Analytical Technologies, Inc. (AATI) simplifies complex genomics workflows to accelerate research and discovery in pharmaceuticals, life science, biofuels, biotechnology and healthcare.

Leave a Reply